The authors present results from an exploratory study conducted to learn more about how Medicaid managed-care plans meet the needs for substance abuse treatment among people with disabilities. These results suggest that capitated health plan staff members are more likely to be knowledgeable about the special needs of people with disabilities who also experience substance abuse problems. Staff members of smaller and more focused health plans demonstrated the greatest knowledge about individuals with disabilities. Staff members of larger behavioral health carve-outs are more likely to develop strategies to achieve population-level goals, such as increased access to care and cost-efficiency. The carve-out plans are likely to offer specialized services only to people with co-occurring mental health and substance abuse problems or to individuals with HIV/AIDS. The authors discuss a number of barriers that make it difficult for managed-care organizations to provide substance abuse treatment services to people with disabilities.
Get full access to this article
View all access options for this article.
References
1.
Adlaf, E.M., Smart, R.G., & Walsh, G.W. (1992). Substance use and work disabilities among a general population. American Journal of Drug & Alcohol Abuse, 18, 371—387.
2.
Bachman, S.S., Drainoni, M.L., & Tobias, C.R. (2003). State policy and practice regarding substance abuse treatment services for Medicaid recipients with disabilities. The American Journal onAddictions, 12, 166—176.
3.
Brown, V.B., Ridgley, M.S., & Pepper, B. (1989). The dual crisis: Mental illness and substance abuse—Present and future directions. American Psychologist , 44, 565—569.
4.
Buss, A., & Cramer, C. (1989). Incidence of alcohol use by people with disabilities: AWisconsin survey of persons with disability. Madison: Wisconsin Department of Health and Human Services.
5.
Drake, R.E., Bartells, S.J., Teague, G.B., Noordsy, D.L., & Clark, R.E. (1993). Treatment of substance abuse in severely mentally ill patients. Journal of Nervous and Mental Disease, 181, 606—611.
6.
Drake, R.E., McLaughlin, P., Pepper, B., & Minkoff, K. (1991). Dual diagnosis of major mental illness and substance disorder: An overview. New Directions in Mental Health Services , 50, 3—12.
7.
Drake, R.E., Osher, F.C., & Wallach, M.A. (1989). Alcohol use and abuse in schizophrenia: A prospective community study. The Journal of Nervous and Mental Disease , 177, 408—414.
8.
Drake, R.E., Teague, G.B., & Warren S.R. (1990). Dual diagnosis: The New Hampshire program. Addiction and Recovery, 10(1), 35—39.
9.
Fann, J.R., Katon, W.J., Uomoto, J.M., & Esselman, P.C. (1995). Psychiatric disorders and functional disability in outpatients with traumatic brain injuries. American Journal of Psychiatry,152, 1493—1499.
10.
Fox, K., Merrill, J.C., Chang, H.H., & Califano, J.A. (1995). Estimating the costs of substance abuse to the Medicaid hospital care program. American Journal of Public Health, 85(1), 48—54.
11.
Glaser, B.G., & Strauss, A.L. (1967). The discovery of grounded theory. New York: AldineDeGruyter.
12.
Gournay, K., Sandford, T., Johnson, S., & Thornicroft, G. (1997). Dual diagnosis of severe mental health problems and substance abuse/dependence: A major priority for mental health nursing. Journal of PsychiatricMental Health Nursing, 4(2), 89—95.
13.
Heinemann, A.W., Doll, M.D., Armstrong, K.J., Schnoll, S., & Yarkony, G.M. (1991). Substance abuse and receipt of treatment by persons with long-term spinal cord injuries. Archives of Physical Medicine and Rehabilitation, 72, 482—487.
14.
Holahan, J., Rangarajan, S., & Shirmer, M. (1999). Medicaid managed care payment methods and capitation rates: Results of a national survey. Washington, DC: The Urban Institute.
15.
Kivlahan, D.R., Heiman, J., Wright, R.C., Mundt, J.W., & Shupe, J.A. (1991). Treatment cost and rehospitalization rate in schizophrenic outpatients with a history of substance abuse. Hospital and Community Psychiatry, 42, 609—614.
16.
Landon, B.E., Huskamp, H.A., Tobias, C., & Epstein, A.M. (2002). The evolution of quality management in state Medicaid agencies: A national survey of states with comprehensive managed care programs. The Joint Commission Journal onQuality Improvement, 28(2), 72—82.
17.
Li, L., & Ford, J.A. (1998). Illicit drug use by women with disabilities. American Journal of Drug and Alcohol Abuse, 24, 405—418.
18.
Moore, D., & Li, L. (1998). Prevalence and risk factors of illicit drug use by people with disabilities. The American Journal onAddictions , 7, 93—102.
19.
Pack, R.P., Wallander, J.L., & Browne, D. (1998). Health risk behaviors of African American adolescents with mild mental retardation: Prevalence depends on measurement. American Journal on Mental Retardation, 102, 409—420.
20.
Poling, C. (1997). Drug abuse in persons with mental retardation: A review. American Journal of Mental Retardation, 102, 126—136.
21.
Regier, D.A., Farmer, M.E., Rae, D.S., Locke, B.Z., Keith, S.J., Judd, L.L., et al. (1990). Comorbidity of mental disorders with alcohol and other drug abuse: Results from the Epidemiologic Catchment Area (ECA) study. Journal of theAmerican Medical Association, 64, 2511—2518.
22.
Safer, D. (1987). Substance abuse by young adult chronic patients . Hospital and Community Psychiatry, 38, 511—514.
23.
Social Security Administration. (1996). Annual statistical supplement to the Social Security Bulletin (Social Security Publication No. 13-11700). Washington, DC: Author.
24.
Substance Abuse and Mental Health Services Administration. (1999). Managed care tracking system. Washington, DC: U.S. Department of Health and Human Services. Retrieved February 7, 2001, from www.samhsa.gov/mc
25.
Tyas, S., & Rush, B. (1993). The treatment of disabled persons with alcohol and drug problems: Results of a survey of addiction services. Journal of Studies on Alcohol, 54, 275—282.
